Doxorubicin vs. Trabectedin Plus Doxorubicin in Non Operable and/or Metastatic STS

This study has been terminated.
(Interim analysis did not show good results for main objective)
Sponsor:
Information provided by (Responsible Party):
Grupo Espanol de Investigacion en Sarcomas
ClinicalTrials.gov Identifier:
NCT01104298
First received: April 13, 2010
Last updated: October 26, 2015
Last verified: October 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: May 2014
  Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)